MD1714F2 - Therapeutical composition in the form of syrup, containing N-acetylcysteine - Google Patents

Therapeutical composition in the form of syrup, containing N-acetylcysteine

Info

Publication number
MD1714F2
MD1714F2 MD96-0265A MD960265A MD1714F2 MD 1714 F2 MD1714 F2 MD 1714F2 MD 960265 A MD960265 A MD 960265A MD 1714 F2 MD1714 F2 MD 1714F2
Authority
MD
Moldova
Prior art keywords
syrup
therapeutical composition
acetylcysteine
agglutinant
edulcorant
Prior art date
Application number
MD96-0265A
Other languages
Romanian (ro)
Other versions
MD1714G2 (en
Inventor
Federico Stroppolo
Daniele Bonadeo
Alessandro Saudino
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of MD1714F2 publication Critical patent/MD1714F2/en
Publication of MD1714G2 publication Critical patent/MD1714G2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

The invention relates to a therapeutical composition in the form of syrup, containing N-acetylcysteine, synthetic edulcorant and agglutinant, as agglutinant being used Na-carboxymethylcellulose or hydroxypropylmethylcellulose or mixes thereof with the following content of substances, calculated for 100 ml, g: N-acetylcystein 2,0...4,2 edulcorant 0,02...0,30 agglutinant 0,1...4,0 water the rest. The therapeutical composition optionally contains aromatizer and conservant, having the pH equal to 5...8.The therapeutical composition may be used in the capacity of cough syrup.Claims: 7
MD96-0265A 1992-12-02 1993-11-23 Therapeutical composition in the form of syrup, containing N-acetylcysteine MD1714G2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI922758A IT1256616B (en) 1992-12-02 1992-12-02 SYRUP CONTAINING N-ACETYL-CISTEIN
PCT/EP1993/003280 WO1994012168A1 (en) 1992-12-02 1993-11-23 Syrup containing n-acetyl-cysteine

Publications (2)

Publication Number Publication Date
MD1714F2 true MD1714F2 (en) 2001-08-31
MD1714G2 MD1714G2 (en) 2002-03-31

Family

ID=11364395

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0265A MD1714G2 (en) 1992-12-02 1993-11-23 Therapeutical composition in the form of syrup, containing N-acetylcysteine

Country Status (23)

Country Link
JP (1) JPH08503703A (en)
AT (1) AT407113B (en)
AU (1) AU667611B2 (en)
BE (1) BE1006799A3 (en)
CA (1) CA2150462C (en)
CH (1) CH685371A5 (en)
CZ (1) CZ282550B6 (en)
DE (2) DE4396086B3 (en)
DK (1) DK176247B1 (en)
ES (1) ES2070806B1 (en)
FR (1) FR2698545B1 (en)
GB (1) GB2288977B (en)
HU (2) HU221484B (en)
IT (1) IT1256616B (en)
LU (1) LU88618A1 (en)
MD (1) MD1714G2 (en)
NL (1) NL194957C (en)
NO (1) NO314018B1 (en)
NZ (1) NZ258544A (en)
RU (1) RU2108777C1 (en)
SE (1) SE520834C2 (en)
UA (1) UA27142C2 (en)
WO (1) WO1994012168A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10502355A (en) * 1994-06-23 1998-03-03 ザ、プロクター、エンド、ギャンブル、カンパニー Topical composition containing N-acetyl-L-cysteine
JP4501023B2 (en) * 2002-11-14 2010-07-14 小林製薬株式会社 Composition with reduced bitterness and odor of cysteines
JP4501024B2 (en) * 2002-11-14 2010-07-14 小林製薬株式会社 Composition with reduced bitterness and odor of cysteines
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
CN102233139B (en) * 2010-04-21 2012-09-05 重庆健能医药开发有限公司 Acetylcysteine effervescent tablet and preparation method and application thereof
RU2611411C1 (en) * 2016-01-11 2017-02-21 Общество с ограниченной ответственностью "Трейдсервис" Dispersible in water acetylcysteine tablet and method of manufacturing thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB905197A (en) * 1960-01-01 1962-09-05 Lab Francais Chimiotherapie Anti-viral compositions comprising 1-phenyl-2-amino-propane-1,3-diol derivatives
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
BE901885A (en) * 1985-03-06 1985-07-01 Bruschettini Srl Stable ophthalmic soln. contg. N-acetyl-cysteine - prepd. in nitrogen satd. aq. buffer free of metal ions
CH667590A5 (en) * 1986-07-24 1988-10-31 Inpharzam Int Sa WATER-SOLUBLE EFFERVESCENT PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN. .
CH666814A5 (en) * 1986-07-24 1988-08-31 Inpharzam Int Sa WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN.
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
CH674940A5 (en) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
IT1234194B (en) * 1988-05-31 1992-05-06 Magis Farmaceutici SYRUP PHARMACEUTICAL COMPOSITIONS CONTAINING PENTITLES AS VEHICULATING AGENTS
ATE87476T1 (en) * 1988-11-10 1993-04-15 Ciba Geigy Ag LIQUID ORAL FORMULATION.
IT1231012B (en) * 1989-07-27 1991-11-08 Zambon Spa PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING NAC.
IT1248998B (en) * 1990-06-26 1995-02-11 Iscofar Sas COMPOSITION OF RUBBER TO BE CHEWED FOR THE PREVENTION AND TREATMENT OF DENTAL PLATE
DK0481294T4 (en) * 1990-10-19 2001-06-18 Spirig Ag Solid, fast-soluble drug preparation containing N-acetylcysteine

Also Published As

Publication number Publication date
LU88618A1 (en) 1995-12-01
JPH08503703A (en) 1996-04-23
CZ282550B6 (en) 1997-08-13
NL194957B (en) 2003-05-01
ITMI922758A1 (en) 1994-06-02
ITMI922758A0 (en) 1992-12-02
GB9509822D0 (en) 1995-07-19
DE4396086B3 (en) 2013-02-28
RU2108777C1 (en) 1998-04-20
NL9320052A (en) 1995-08-01
CZ136795A3 (en) 1995-11-15
ES2070806B1 (en) 1996-01-01
HU211912A9 (en) 1996-01-29
CA2150462A1 (en) 1994-06-09
SE9502001L (en) 1995-07-21
SE520834C2 (en) 2003-09-02
NO952183D0 (en) 1995-06-01
FR2698545A1 (en) 1994-06-03
AU667611B2 (en) 1996-03-28
DE4396086T1 (en) 1995-12-07
HUT72668A (en) 1996-05-28
SE9502001D0 (en) 1995-06-01
MD1714G2 (en) 2002-03-31
AU5626694A (en) 1994-06-22
UA27142C2 (en) 2000-02-28
GB2288977A (en) 1995-11-08
CA2150462C (en) 2005-04-19
NO952183L (en) 1995-06-01
BE1006799A3 (en) 1994-12-13
ES2070806A1 (en) 1995-06-01
FR2698545B1 (en) 1995-08-04
HU9501586D0 (en) 1995-08-28
CH685371A5 (en) 1995-06-30
NZ258544A (en) 1996-11-26
NO314018B1 (en) 2003-01-20
WO1994012168A1 (en) 1994-06-09
HU221484B (en) 2002-10-28
GB2288977B (en) 1996-09-04
DK61495A (en) 1995-05-31
IT1256616B (en) 1995-12-12
NL194957C (en) 2003-09-02
DK176247B1 (en) 2007-04-16
ATA906093A (en) 2000-05-15
AT407113B (en) 2000-12-27

Similar Documents

Publication Publication Date Title
IL111121A (en) Compositions which are useful in agriculture and which contain alkylsilicones
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
IL85934A0 (en) Compositions for desorbing bacteria
AU1520188A (en) Compositions and methods of treatment of timber
MD1714F2 (en) Therapeutical composition in the form of syrup, containing N-acetylcysteine
NZ337798A (en) Pharmaceutical compositions containing lamivudine
BG103306A (en) Liquid allendronate compositions
EG18776A (en) Hydrazone compound and production thereof and inseticidal composition containing the same
GB2261580B (en) Improvements in or relating to the decoding of signals
EP0461261A4 (en) Oligopeptide mixture and composition containing the same.
AU2375788A (en) Improvements in and relating to the installation of tensioned rockbolts
GB2201623B (en) Improvements in and relating to the purging of pipework
AU3487189A (en) Improvements in or relating to fencing
YU22499A (en) Stabilised pharmaceutical compositions with quinupristine and dalfopristine base and their preparation
GR890100849A (en) Chemical and bacteriological composition for the porification of sandy soils
EP0577699A4 (en) Compositions and methods to inhibit the activation of active factor xiii.
AU4450489A (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
GB2259507B (en) Improvements in or relating to the tightening of closures
GB8903423D0 (en) Improvements in or relating to the construction of drawers for furniture
GB9203655D0 (en) Improvements in or relating to the drilling of material
AU2528792A (en) Improvements in or relating to composting
BG101054A (en) Fungicide mixtures
GB9315318D0 (en) Improvements in or relating to the playing of bingo
AU2101988A (en) Improvements in or relating to galvanising fluxes
GB9314103D0 (en) Improvements in or relating to valves

Legal Events

Date Code Title Description
PD99 Pending application
MK4A Patent for invention expired